Tenet Healthcare price target raised to $45 from $40 at Loop Capital

Loop Capital analyst Joseph France raised the firm’s price target on Tenet Healthcare to $45 from $40 and keeps a Hold rating on the shares. The analyst states that he still expects some continuation of the labor challenges, but the situation seems to be improving and there could also be a longer wait until a pickup in Tenet’s SurgCenter Development joint venture buy-ups. A pickup in volume and a return to rapid growth at the ASC business could spark a recovery in Tenet’s stock, though the most attractive outcome would be to separate the company’s hospital and ASC business, France tells investors in a research note.